Erlotinib Completed Phase N/A Trials for Stage IV Non-Small Cell Lung Cancer / Non-Small Cell Lung Cancer Recurrent / Stage IIIb Non-small Cell Lung Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00085280Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer